---
title: "BIOX Q4'26 Earnings: EPS estimate is (0.06) USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298721362.md"
description: "BIOX (Bioceres Crop Solutions Corp.) is set to announce its Q4'26 results on September 14, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q4'26, revenue estimate is 79.00 million USD with EPS (earnings per share) anticipated at (0.06) USD. Learn more details at .Revenue & EPS values are provided in USDQ4'25Q1'26Q2'26Q3'26Q4'26Revenue Reported74.70 M77.50 M—39.40 M—Revenue Estimate110.08 M94.63 M96.00 M54.50 M79.00 MRevenue Surprise-32.14%-18.10%-27.71%EPS Reported(0.70)(0.12)(0.16) EPS Estimate0.07(0.06) 0.07(0.05)(0.06) EPS Surprise-1138.44%-86.79%-214.47%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc."
datetime: "2026-09-11T11:00:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298721362.md)
  - [en](https://longbridge.com/en/news/298721362.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298721362.md)
generator: "portal-rs"
---

# BIOX Q4'26 Earnings: EPS estimate is (0.06) USD

BIOX (Bioceres Crop Solutions Corp.) is set to announce its Q4'26 results on September 14, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q4'26, revenue estimate is 79.00 million USD with EPS (earnings per share) anticipated at (0.06) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

|                      | Q4'25     | Q1'26   | Q2'26   | Q3'26    | Q4'26   |
| -------------------- | --------- | ------- | ------- | -------- | ------- |
| **Revenue Reported** | 74.70 M   | 77.50 M | —       | 39.40 M  | —       |
| **Revenue Estimate** | 110.08 M  | 94.63 M | 96.00 M | 54.50 M  | 79.00 M |
| **Revenue Surprise** | -32.14%   | -18.10% |         | -27.71%  |         |
| **EPS Reported**     | (0.70)    | (0.12)  |         | (0.16)   |         |
| **EPS Estimate**     | 0.07      | (0.06)  | 0.07    | (0.05)   | (0.06)  |
| **EPS Surprise**     | -1138.44% | -86.79% |         | -214.47% |         |

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [BIOX.US](https://longbridge.com/en/quote/BIOX.US.md)

## Related News & Research

- [BIOX Q4'26 Earnings: EPS estimate is (0.06) USD](https://longbridge.com/en/news/297774037.md)
- [BIOX: Stable 4Q26 revenues and improved cost controls offset ongoing net losses and portfolio transitions](https://longbridge.com/en/news/298970405.md)
- [Nebius COO Nave Ophir disposes of USD 113.38 million in Class A shares](https://longbridge.com/en/news/301073075.md)
- [Personalis-Tempus AI deal clears US antitrust waiting period under HSR Act](https://longbridge.com/en/news/301072040.md)
- [BIOX Q3'26 Earnings: EPS estimate is (0.05) USD](https://longbridge.com/en/news/285928574.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**